Congress expands Medicare to ages 50–64, boosts ACA subsidies, stabilizes markets

What it does

This bill creates a Medicare buy-in option for people ages 50–64 who are not yet eligible for Medicare, allowing them to purchase Medicare coverage at actuarially sound premiums with income-based subsidies similar to ACA marketplace plans. It also establishes a direct supplemental insurance program, expands Medicare's authority to negotiate Part D drug prices, creates an individual market reinsurance fund to stabilize premiums, extends risk corridors, and increases the income threshold for ACA premium tax credits to 400% of poverty (removing the current cap).

Why we flagged it

The bill's core mechanism is expanding access to affordable health coverage through three channels: a new Medicare buy-in for near-retirees, enhanced ACA subsidies for lower-income enrollees, and market stabilization tools (reinsurance, risk corridors, drug price negotiation). It is fundamentally a public-coverage and affordability measure, not a deregulation or industry carve-out.

• Section 9 repeals Subtitle B of title VII of Public Law 119–21 (reconciliation act). This is substantively unrelated to the bill's stated purpose of expanding Medicare and stabilizing markets; it appears to undo prior legislative action on unspecified health provisions.

What the text implies

• The Medicare buy-in premium is set actuarially but subsidized via transferred ACA credits; if enrollment is lower than projected, the Trust Fund may face solvency pressure, requiring future premium increases or benefit cuts.
• Section 1882(aa) requires Medigap insurers to accept all Medicare buy-in enrollees during a 30-day window post-enrollment, potentially increasing Medigap claims and premiums for existing Medigap enrollees if adverse selection occurs.
• The individual market reinsurance fund is financed by a fee on participating QHPs; this cost may be passed to enrollees as higher premiums, offsetting some stabilization benefit.
• Section 5 grants the Secretary broad authority to negotiate Part D drug prices but does not specify negotiation methodology, pricing floors, or manufacturer participation requirements; implementation details will determine actual savings.
• The repeal of reconciliation health provisions (Section 9) is vague—the bill does not identify which provisions are being undone, creating uncertainty about downstream effects on other health programs.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands affordable coverage pathways for two vulnerable populations: near-retirees (50–64) gain a Medicare option with income-based subsidies, and lower-income ACA marketplace enrollees receive enhanced premium tax credits. The individual market reinsurance fund and risk corridor extension stabilize premiums for all marketplace plans. Medicare drug price negotiation authority may reduce out-of-pocket costs for beneficiaries. The primary beneficiaries are uninsured or underinsured near-r

Who stands to gain

• Individuals ages 50–64 with income below 400% of poverty (premium subsidies)
• Lower-income ACA marketplace enrollees (enhanced premium tax credits)
• Health insurance issuers (reinsurance payments for high-cost enrollees)
• Pharmaceutical manufacturers (negotiation authority may reduce prices, but scope is unclear)

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS), Department of the Treasury, National Association of Insurance Commissioners (NAIC), Health insurance issuers, Pharmaceutical manufacturers, States, Nonprofit community-based organizations

Where it stands

• Mar 12, 2026 — Introduced · Congress.gov: “Introduced in House”
• Mar 12, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.